[Advances in antibody-conjugating drugs in prostate cancer: applications and challenges].

In recent years, significant progress has been made in the structural optimization and mechanistic research of antibody-drug conjugates (ADC), with multiple clinical trials for prostate cancer underway and demonstrating broad clinical application pro…

Preview only. Read the full abstract at the source